Abstract |
Since its FDA approval in 1999, photodynamic therapy ( PDT) with topical 5-aminolevulinic acid has become an increasingly popular modality for the treatment of actinic keratosis (AKs). It is hoped that in addition to improving clinical signs and symptoms of AKs, PDT might prevent the development of skin cancer. We present a case of a patient developing a keratoacanthoma immediately following PDT for AKs.
|
Authors | Elena Maydan, Pavan K Nootheti, Mitchel P Goldman |
Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
Vol. 5
Issue 8
Pg. 804-6
(Sep 2006)
ISSN: 1545-9616 [Print] United States |
PMID | 16989196
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Photosensitizing Agents
- Aminolevulinic Acid
|
Topics |
- Administration, Topical
- Aminolevulinic Acid
(adverse effects)
- Humans
- Keratoacanthoma
(chemically induced)
- Keratosis
(drug therapy)
- Male
- Middle Aged
- Photochemotherapy
(adverse effects)
- Photosensitizing Agents
(adverse effects)
|